Small molecule DnaK modulators targeting the beta-domain.
The molecular chaperone DnaK is essential for the survival of bacterial pathogens in the hostile environment of the host. Hence, it is in principle a promising target for drug design but for which no current inhibitors are available apart from certain antimicrobial peptides. To this end, we have screened libraries of small molecules for their ability to interact with the substrate-binding domain of DnaK. The most promising hit from the screen was synthesized and along with its analogs subjected to further assays to determine their binding affinity and ability to interfere with bacterial growth. This work resulted in the identification of a number of compounds that bind with submicromolar affinity and capable of inhibiting Yersinia pseudotuberculosis growth more effectively than the previously characterized peptides.
Cellitti
Jason
J
Burnham Institute for Medical Research, La Jolla, CA 92037, USA.
Zhang
Ziming
Z
Wang
Si
S
Wu
Bainan
B
Yuan
Hongbin
H
Hasegawa
Patty
P
Guiney
Donald G
DG
Pellecchia
Maurizio
M
D000595:Amino Acid Sequence; D000900:Anti-Bacterial Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D001665:Binding Sites; D003198:Computer Simulation; D029968:Escherichia coli Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism; D018840:HSP70 Heat-Shock Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism; D008826:Microbial Sensitivity Tests; D008969:Molecular Sequence Data; D010455:Peptides / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D017434:Protein Structure, Tertiary; D016415:Sequence Alignment; D017386:Sequence Homology, Amino Acid; D013329:Structure-Activity Relationship
D000900:Anti-Bacterial Agents; D029968:Escherichia coli Proteins; D018840:HSP70 Heat-Shock Proteins; D010455:Peptides; C063842:dnaK protein, E coli
Nature. 2004 Mar 18;428(6980):341-5
15029200
J Biol Chem. 1995 Jul 14;270(28):16903-10
7622507
J Med Chem. 2006 Dec 28;49(26):7721-30
17181154
Cell Mol Life Sci. 2002 Oct;59(10):1598-606
12475169
Methods Mol Biol. 2003;232:67-76
12840540
Nature. 1990 Aug 16;346(6285):623-8
2143562
Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10345-9
7937953
Mol Cell. 2007 Apr 13;26(1):27-39
17434124
J Microbiol Biotechnol. 2008 Feb;18(2):228-33
18309265
J Med Chem. 2009 Mar 26;52(6):1510-3
19256508
Infect Immun. 2004 Mar;72(3):1364-73
14977940
J Biol Chem. 2008 May 30;283(22):15502-11
18400763
Biochemistry. 2001 Mar 13;40(10):3016-26
11258915
Mol Cell. 2005 Nov 23;20(4):513-24
16307916
Curr Opin Drug Discov Devel. 2002 Sep;5(5):713-7
12630291
FEBS Lett. 2004 May 7;565(1-3):65-9
15135054
Science. 1996 Jun 14;272(5268):1606-14
8658133
Chem Biol Drug Des. 2006 Sep;68(3):148-53
17062012
Protein Sci. 2003 Nov;12(11):2588-96
14573869
Annu Rev Biophys Biomol Struct. 1996;25:137-62
8800467
Biophys J. 2006 Jul 15;91(2):496-507
16648174
Anticancer Agents Med Chem. 2008 Oct;8(7):761-82
18855578
J Biol Chem. 2006 Dec 15;281(50):38705-11
17052976
Mol Microbiol. 2007 Nov;66(4):840-57
17919282
Mol Cell. 2006 Feb 3;21(3):359-67
16455491
Cell Mol Life Sci. 2005 Mar;62(6):670-84
15770419
Cell. 2006 May 5;125(3):443-51
16678092
Cancer Res. 2006 Feb 1;66(3):1783-91
16452239
J Med Chem. 2007 Dec 27;50(26):6607-17
18038971
Cell. 2007 Oct 5;131(1):106-20
17923091
Proteins. 2003 Sep 1;52(4):609-23
12910460
J Bacteriol. 2002 Dec;184(24):7047-54
12446654
Curr Opin Struct Biol. 2006 Feb;16(1):102-8
16423525
Microbiol Immunol. 1994;38(4):295-300
7935048
FEBS Lett. 2007 Jul 31;581(19):3702-10
17544402
J Biol Chem. 1994 May 6;269(18):13107-14
8175736
Biochemistry. 2000 Nov 21;39(46):14150-9
11087363
J Mol Biol. 2005 May 27;349(1):163-83
15876376
Nat Struct Biol. 2002 Jun;9(6):419-24
12021775
Nat Rev Mol Cell Biol. 2004 Oct;5(10):781-91
15459659
Nat Struct Biol. 2000 Apr;7(4):298-303
10742174
J Biol Chem. 1995 Feb 3;270(5):2251-7
7836458